Ginkgo bioworks appoints dr. behzad mahdavi as senior vice president of biopharma manufacturing & life science tools

Boston , sept. 1, 2022 /prnewswire/ -- ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, today announced that behzad mahdavi, ph.d.

DNA Ratings Summary

DNA Quant Ranking